Alan Fuhrman
Chief Financial Officer · Tyra Biosciences, Inc.
- 2024
- Sep 17, 2026
- 8
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Alan Fuhrman files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- RA CAPITAL MANAGEMENT, L.P. - $199.99M in TYRA purchases and sales in the last 12 months
- Robert J. More - $5.25M in TYRA purchases and sales in the last 12 months
- Daniel Bensen - $4.81M in TYRA purchases and sales in the last 12 months
- Gilla Kaplan - $529K in TYRA purchases and sales in the last 12 months
- Rehan Verjee - $20K in TYRA purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Alan Fuhrman?
Alan Fuhrman is a corporate insider, tracked as Chief Financial Officer of Tyra Biosciences, Inc. (TYRA). InsiderAlpha holds 8 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Alan Fuhrman submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Alan Fuhrman been buying or selling stock?
Recorded transactions: 1 open-market purchase ($152K) and 0 open-market sales across all tracked filings.
